HEALTHY SUBJECTS (HS)
Clinical trials for HEALTHY SUBJECTS (HS) explained in plain language.
Never miss a new study
Get alerted when new HEALTHY SUBJECTS (HS) trials appear
Sign up with your email to follow new studies for HEALTHY SUBJECTS (HS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug ISM8969 enters first human safety tests
Knowledge-focused Not yet recruitingThis early-stage study tests whether a new oral drug called ISM8969 is safe and how the body processes it. About 100 healthy adults, elderly people, and obese adults at risk for heart disease will receive either the drug or a placebo. The goal is to check for side effects and mea…
Matched conditions: HEALTHY SUBJECTS (HS)
Phase: PHASE1 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Knowledge-focused
Last updated May 17, 2026 08:54 UTC
-
Skin oil analysis could reveal hidden biomarkers for common skin conditions
Knowledge-focused Not yet recruitingThis study aims to create a standard method for collecting and analyzing skin oil (sebum) to find biomarkers for skin diseases like acne, eczema, and psoriasis. Researchers will study 200 participants, including healthy people and those with skin conditions, to see how skin oil c…
Matched conditions: HEALTHY SUBJECTS (HS)
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated May 12, 2026 13:40 UTC
-
Hydrogen gas may shield Divers' lungs from oxygen poisoning
Knowledge-focused Not yet recruitingThis study tests whether adding a small amount of hydrogen to the breathing gas can reduce lung damage caused by breathing high levels of oxygen under pressure. Thirty-two healthy military divers will breathe either hydrogen-enriched or standard oxygen gas during two separate ses…
Matched conditions: HEALTHY SUBJECTS (HS)
Phase: NA • Sponsor: Blekinge Institute of Technology • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC
-
New drug ISH0613 tested in humans for first time
Knowledge-focused Not yet recruitingThis early-stage study tests a new drug called ISH0613 in 26 healthy adults to see if it is safe and how the body handles it. Participants get a single dose of the drug or a placebo and are closely monitored for side effects. The results will help guide future research in conditi…
Matched conditions: HEALTHY SUBJECTS (HS)
Phase: PHASE1 • Sponsor: SUNHO（China）BioPharmaceutical CO., Ltd. • Aim: Knowledge-focused
Last updated May 07, 2026 18:38 UTC